A statewide effort to reduce high-dose opioid prescribing through coordinated care organizations

Daniel M. Hartung, Lindsey Alley, Gillian Leichtling, Philip (Todd) Korthuis, Christi Hildebran

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Oregon's Medicaid program is delivered through 16 Coordinated Care Organizations (CCOs) participating in a statewide performance improvement program to reduce high-dose opioid prescribing. CCOs were allowed flexibility to develop their own dose targets and any policies, trainings, guidelines, and/or materials to meet these targets. In this study, we characterize CCO strategies to reduce high-dose opioid prescribing across the 16 CCOs. Methods: We reviewed relevant CCO documents and conducted semi-structured interviews with CCO administrators to acquire opioid-related policies, practices, timelines and contextual factors. We applied a systematic coding procedure to develop a comprehensive description of each CCO's strategy. We used administrative data from the state to summarize contextual utilization data for each CCO. Results: Most CCOs selected a target daily morphine milligram equivalent (MME) dose of 90 mg. Sixteen issued quantity limits related to dose, eight restricted specific drug formulations (short-acting or long-acting), and 11 allowed for time-limited taper plan periods for patients over threshold. Many CCOs also employed provider trainings, feedback reports, and/or onsite technical assistance. Other innovations included incentive measures, electronic health record alerts, and toolkits with materials on local alternative therapy resources and strategies for patient communication. CCOs leveraging collaborations with regional partners appeared to mount a greater intensity of interventions than independently operating CCOs. Conclusions: CCOs developed a diversity of interventions to confront high-risk opioid prescribing within their organization. As healthcare systems mount interventions to reduce risky opioid prescribing, it is critical to carefully describe these activities and examine their impact on process and health outcomes.

Original languageEnglish (US)
JournalAddictive Behaviors
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Opioid Analgesics
Organizations
Health
Drug Compounding
Electronic Health Records
Medicaid
Complementary Therapies
Administrative Personnel
Morphine
Motivation
Innovation
Communication
Guidelines
Interviews
Delivery of Health Care
Feedback

Keywords

  • Coordinated care
  • Opioid
  • Opioid policy
  • Opioid safety interventions
  • Prescribing limits
  • Tapering

ASJC Scopus subject areas

  • Medicine (miscellaneous)
  • Toxicology
  • Clinical Psychology
  • Psychiatry and Mental health

Cite this

A statewide effort to reduce high-dose opioid prescribing through coordinated care organizations. / Hartung, Daniel M.; Alley, Lindsey; Leichtling, Gillian; Korthuis, Philip (Todd); Hildebran, Christi.

In: Addictive Behaviors, 01.01.2018.

Research output: Contribution to journalArticle

Hartung, Daniel M. ; Alley, Lindsey ; Leichtling, Gillian ; Korthuis, Philip (Todd) ; Hildebran, Christi. / A statewide effort to reduce high-dose opioid prescribing through coordinated care organizations. In: Addictive Behaviors. 2018.
@article{f887b44d960142898c43a49520ee6138,
title = "A statewide effort to reduce high-dose opioid prescribing through coordinated care organizations",
abstract = "Background: Oregon's Medicaid program is delivered through 16 Coordinated Care Organizations (CCOs) participating in a statewide performance improvement program to reduce high-dose opioid prescribing. CCOs were allowed flexibility to develop their own dose targets and any policies, trainings, guidelines, and/or materials to meet these targets. In this study, we characterize CCO strategies to reduce high-dose opioid prescribing across the 16 CCOs. Methods: We reviewed relevant CCO documents and conducted semi-structured interviews with CCO administrators to acquire opioid-related policies, practices, timelines and contextual factors. We applied a systematic coding procedure to develop a comprehensive description of each CCO's strategy. We used administrative data from the state to summarize contextual utilization data for each CCO. Results: Most CCOs selected a target daily morphine milligram equivalent (MME) dose of 90 mg. Sixteen issued quantity limits related to dose, eight restricted specific drug formulations (short-acting or long-acting), and 11 allowed for time-limited taper plan periods for patients over threshold. Many CCOs also employed provider trainings, feedback reports, and/or onsite technical assistance. Other innovations included incentive measures, electronic health record alerts, and toolkits with materials on local alternative therapy resources and strategies for patient communication. CCOs leveraging collaborations with regional partners appeared to mount a greater intensity of interventions than independently operating CCOs. Conclusions: CCOs developed a diversity of interventions to confront high-risk opioid prescribing within their organization. As healthcare systems mount interventions to reduce risky opioid prescribing, it is critical to carefully describe these activities and examine their impact on process and health outcomes.",
keywords = "Coordinated care, Opioid, Opioid policy, Opioid safety interventions, Prescribing limits, Tapering",
author = "Hartung, {Daniel M.} and Lindsey Alley and Gillian Leichtling and Korthuis, {Philip (Todd)} and Christi Hildebran",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.addbeh.2018.04.020",
language = "English (US)",
journal = "Addictive Behaviors",
issn = "0306-4603",
publisher = "Elsevier Limited",

}

TY - JOUR

T1 - A statewide effort to reduce high-dose opioid prescribing through coordinated care organizations

AU - Hartung, Daniel M.

AU - Alley, Lindsey

AU - Leichtling, Gillian

AU - Korthuis, Philip (Todd)

AU - Hildebran, Christi

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Oregon's Medicaid program is delivered through 16 Coordinated Care Organizations (CCOs) participating in a statewide performance improvement program to reduce high-dose opioid prescribing. CCOs were allowed flexibility to develop their own dose targets and any policies, trainings, guidelines, and/or materials to meet these targets. In this study, we characterize CCO strategies to reduce high-dose opioid prescribing across the 16 CCOs. Methods: We reviewed relevant CCO documents and conducted semi-structured interviews with CCO administrators to acquire opioid-related policies, practices, timelines and contextual factors. We applied a systematic coding procedure to develop a comprehensive description of each CCO's strategy. We used administrative data from the state to summarize contextual utilization data for each CCO. Results: Most CCOs selected a target daily morphine milligram equivalent (MME) dose of 90 mg. Sixteen issued quantity limits related to dose, eight restricted specific drug formulations (short-acting or long-acting), and 11 allowed for time-limited taper plan periods for patients over threshold. Many CCOs also employed provider trainings, feedback reports, and/or onsite technical assistance. Other innovations included incentive measures, electronic health record alerts, and toolkits with materials on local alternative therapy resources and strategies for patient communication. CCOs leveraging collaborations with regional partners appeared to mount a greater intensity of interventions than independently operating CCOs. Conclusions: CCOs developed a diversity of interventions to confront high-risk opioid prescribing within their organization. As healthcare systems mount interventions to reduce risky opioid prescribing, it is critical to carefully describe these activities and examine their impact on process and health outcomes.

AB - Background: Oregon's Medicaid program is delivered through 16 Coordinated Care Organizations (CCOs) participating in a statewide performance improvement program to reduce high-dose opioid prescribing. CCOs were allowed flexibility to develop their own dose targets and any policies, trainings, guidelines, and/or materials to meet these targets. In this study, we characterize CCO strategies to reduce high-dose opioid prescribing across the 16 CCOs. Methods: We reviewed relevant CCO documents and conducted semi-structured interviews with CCO administrators to acquire opioid-related policies, practices, timelines and contextual factors. We applied a systematic coding procedure to develop a comprehensive description of each CCO's strategy. We used administrative data from the state to summarize contextual utilization data for each CCO. Results: Most CCOs selected a target daily morphine milligram equivalent (MME) dose of 90 mg. Sixteen issued quantity limits related to dose, eight restricted specific drug formulations (short-acting or long-acting), and 11 allowed for time-limited taper plan periods for patients over threshold. Many CCOs also employed provider trainings, feedback reports, and/or onsite technical assistance. Other innovations included incentive measures, electronic health record alerts, and toolkits with materials on local alternative therapy resources and strategies for patient communication. CCOs leveraging collaborations with regional partners appeared to mount a greater intensity of interventions than independently operating CCOs. Conclusions: CCOs developed a diversity of interventions to confront high-risk opioid prescribing within their organization. As healthcare systems mount interventions to reduce risky opioid prescribing, it is critical to carefully describe these activities and examine their impact on process and health outcomes.

KW - Coordinated care

KW - Opioid

KW - Opioid policy

KW - Opioid safety interventions

KW - Prescribing limits

KW - Tapering

UR - http://www.scopus.com/inward/record.url?scp=85046751541&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046751541&partnerID=8YFLogxK

U2 - 10.1016/j.addbeh.2018.04.020

DO - 10.1016/j.addbeh.2018.04.020

M3 - Article

JO - Addictive Behaviors

JF - Addictive Behaviors

SN - 0306-4603

ER -